ANTEROGEN CO., LTD.
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
065660 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 디지털로 130, 405호(가산동, 남성플라자), 서울특별시
- Website:
- http://anterogen.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Anterogen Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of cell therapy products and orphan drugs. The company's core technology leverages adult stem cells, particularly adipose-derived stem cells (ASCs), to create treatments for various medical conditions. Established with a research institute in 2000, Anterogen was a pioneer in the commercialization of ASC-based therapies in its domestic market. Its product pipeline is developed through clinical trials and focuses on leveraging the immune-modulating effects of its proprietary stem cell technology. The company manages the full lifecycle of its products, from research to manufacturing and distribution.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ANTEROGEN CO., LTD. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all ANTEROGEN CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ANTEROGEN CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
